Trulieve Cannabis (NYSE:TRLV) Shares Climb 3.8% – What’s Next?

Trulieve Cannabis Corp. (NYSE:TRLV) shot up 3.8% on Monday. The stock traded as high as $12.28 and last traded at $12.6750. 113,563 shares changed hands during mid-day trading, a decline of 87% from the average daily volume of 865,477 shares. The stock had previously closed at $12.21.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Zacks Research raised Trulieve Cannabis to a “hold” rating in a report on Thursday, June 18th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $15.00 price target on shares of Trulieve Cannabis in a research note on Friday, August 7th. Wall Street Zen cut shares of Trulieve Cannabis from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Trulieve Cannabis in a research note on Friday, September 11th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $15.00.

Trulieve Cannabis Stock Up 2.1%

The firm’s fifty day simple moving average is $10.38.

Trulieve Cannabis (NYSE:TRLV) last posted its quarterly earnings results on Friday, August 7th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.05. The business had revenue of $271.00 million for the quarter, compared to analyst estimates of $268.82 million. As a group, equities research analysts predict that Trulieve Cannabis Corp. will post 0.31 earnings per share for the current year.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis company that cultivates, processes, manufactures and sells medical and adult-use cannabis products. Its product portfolio includes flower, pre-rolls, concentrates, edibles, tinctures, capsules and topical products, marketed under the Trulieve brand and other affiliated brands.

The company sells its products through a network of company-operated dispensaries and, where permitted, through wholesale and other distribution channels.